Efficacy and safety of dupilumab in bullous pemphigoid: a retrospective multicentric study of 36 patients

被引：10
|
作者：
Moghadam, Parna [1 ]
Tancrede, Emmanuelle [1 ]
Bouaziz, Jean-David [1 ]
Kallout, Julien
Bedane, Christophe
Begon, Edouard
Bourgault-Villada, Isabelle
Calugareanu, Andreea
Dereure, Olivier
Jendoubi, Fatma
Pham-Ledard, Anne
Ingen-Housz-Oro, Saskia
Picard-Dahan, Catherine
Viguier, Manuelle
Mahevas, Thibault [1 ]
Jachiet, Marie [1 ]
Charvet, Estelle [1 ]
Cassius, Charles [1 ]
Alexandre, Marina
Lepelletier, Clemence [1 ]
Groupe Bulles French Society Dermatology
机构：
[1] St Louis Hosp, Dermatol Dept, Paris, France
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 02期
关键词：
D O I：
10.1093/bjd/ljad136
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Bullous pemphigoid (BP) is the most common autoimmune blistering disease in Europe and its treatment can be challenging. Several published cases have reported dupilumab efficiency in treatment-refractory patients. We conducted a retrospective multicentric study of 36 patients to evaluate the real-life efficiency of dupilumab in BP. Our results suggest that dupilumab, in association with high-potency topical steroids, could be rapidly effective in various clinical forms of BP and seems to be well tolerated in the elderly.
引用
收藏
页码：244 / 246
页数：3
相关论文
共 50 条
  • [1] Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
    Zhang, Yihua
    Xu, Qiuyun
    Chen, Lihong
    Chen, Jiawen
    Zhang, Jing
    Zou, Ying
    Gong, Ting
    Ji, Chao
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [2] The efficacy and safety of dupilumab combined with methylprednisolone in the treatment of bullous pemphigoid in China
    Wang, Qi
    Xia, Rushan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 118
  • [3] Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
    Wang, Si-Hang
    Zuo, Ya-Gang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [4] Long-term efficacy and safety of dupilumab for severe bullous pemphigoid: A prospective cohort study
    Huang, Dawei
    Zhang, Yuexin
    Yu, Yingyuan
    Jiang, Yuxiong
    Kong, Luyang
    Ding, Yangfeng
    Shi, Yuling
    Gao, Yunlu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [5] Evaluation of Dupilumab in Patients With Bullous Pemphigoid
    Zhao, Liuqi
    Wang, Qijun
    Liang, Guirong
    Zhou, Yuxi
    Yiu, Nam
    Yang, Baoqi
    Zhang, Guiying
    Li, Wei
    Feng, Suying
    Shang, Panpan
    Chen, Xixue
    Zhu, Xuejun
    Zheng, Jie
    Pan, Meng
    Wang, Mingyue
    JAMA DERMATOLOGY, 2023, 159 (09) : 953 - 960
  • [6] Fast Itch Relief during Dupilumab Predicts Clinical Efficacy in Bullous Pemphigoid: A Retrospective Cohort Study
    Thevan, Jeivicaa
    Schmauch, Eloi
    Nilsson, Jakob
    Guillet, Carole Florence
    Boesch, Andrea
    Krahenbuhl, Lukas
    Meier-Schiesser, Barbara
    Schmid-Grendelmeier, Peter
    Kundig, Thomas
    Kolios, Antonios G. A.
    DERMATOLOGY, 2024, 240 (5-6) : 694 - 701
  • [7] Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study
    Napolitano, M.
    Fabbrocini, G.
    Scalvenzi, M.
    Blasio, C.
    Stingeni, L.
    Patruno, C.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2020, 45 (07) : 888 - 890
  • [8] Long-term treatment outcomes and safety of dupilumab as a therapy for bullous pemphigoid: A multicenter retrospective review
    Learned, Christine
    Cohen, Stephanie R.
    Cunningham, Kaitlynne
    Alsukait, Sarah
    Santiago, Sueheidi
    Lu, Jun
    Rothe, Marti
    Nichols, Anna
    Rosmarin, David
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (02) : 378 - 382
  • [9] Efficacy and safety of methotrexate, omalizumab and dupilumab for bullous pemphigoid in patients resistant or contraindicated to oral steroids. A monocentric real-life study
    Velin, M.
    Dugourd, P. -M.
    Sanchez, A.
    Bahadoran, P.
    Montaudie, H.
    Passeron, T.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) : E539 - E542
  • [10] Dupilumab combined with low-dose systemic steroid therapy improves efficacy and safety for bullous pemphigoid
    Yang, Jin
    Gao, Haiqing
    Zhang, Zhen
    Tang, Chang
    Chen, Zihua
    Wang, Lanting
    Yang, Fanping
    Chen, Shengan
    He, Shan
    Liu, Shutao
    Tang, Lin
    Xu, Yu
    Hu, Yao
    Ma, Li
    Zhao, Ying
    Luo, Xiaoqun
    DERMATOLOGIC THERAPY, 2022, 35 (08)
12345